Astron Corporation Limited
Astron Corporation Limited (ATR.AX) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Astron Corporation Limited (ATR.AX), featuring income statements, balance sheets, and cash flow data.
Astron Corporation Limited (ATR.AX) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Astron Corporation Limited ATR.AX financial performance.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $5.94M | $6.27M | $7.69M | $6.77M |
| Cost of Revenue | $8.03M | $7.76M | $8.02M | $8.25M |
| Gross Profit | -$2.09M | -$1.49M | -$333980.00 | -$1.48M |
| Gross Profit Ratio | -$0.35 | -$0.24 | -$0.04 | -$0.22 |
| R&D Expenses | $0.00 | $0.00 | $163407.00 | $163407.00 |
| SG&A Expenses | $4.73M | $3.87M | $2.22M | $2.62M |
| Operating Expenses | $4.73M | $14.31M | $2.22M | $2.62M |
| Total Costs & Expenses | $12.76M | $22.06M | $10.24M | $10.87M |
| Interest Income | $810.00 | $264.00 | $157.00 | $317.00 |
| Interest Expense | $0.00 | $1.03M | $671283.00 | $514511.00 |
| Depreciation & Amortization | $887015.00 | $760446.00 | $1.15M | $878958.00 |
| EBITDA | -$5.92M | -$4.99M | -$1.22M | -$3.15M |
| EBITDA Ratio | -$1.00 | -$0.80 | -$0.18 | -$0.48 |
| Operating Income | -$6.82M | -$5.75M | -$2.55M | -$4.10M |
| Operating Income Ratio | -$1.15 | -$0.92 | -$0.33 | -$0.61 |
| Other Income/Expenses (Net) | $699502.00 | -$10.85M | -$486499.00 | -$447087.00 |
| Income Before Tax | -$6.12M | -$16.21M | -$3.04M | -$4.54M |
| Income Before Tax Ratio | -$1.03 | -$2.58 | -$0.40 | -$0.67 |
| Income Tax Expense | $1.68M | $858093.00 | -$368069.00 | $516364.00 |
| Net Income | -$7.80M | -$17.07M | -$2.67M | -$5.06M |
| Net Income Ratio | -$1.31 | -$2.72 | -$0.35 | -$0.75 |
| EPS | -$0.05 | -$0.11 | -$0.02 | -$0.04 |
| Diluted EPS | -$0.05 | -$0.11 | -$0.02 | -$0.04 |
| Weighted Avg Shares Outstanding | $166.38M | $149.65M | $122.48M | $124.68M |
| Weighted Avg Shares Outstanding (Diluted) | $166.38M | $149.65M | $122.48M | $124.68M |
The company's financials show resilient growth, with revenue advancing from $6.77M in Q2 2023 to $5.94M in Q4 2024. Gross profit remained healthy with margins at -35% in Q4 2024 compared to -22% in Q2 2023. Operating income hit -$6.82M last quarter, sustaining a consistent -115% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$5.92M. Net income rose to -$7.80M, while earnings per share reached -$0.05. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan